Dixon Hubard Feinour & Brown’s NeueHealth NEUE Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$27K	Buy	+188	New	+$27.4K	﹤0.01%	278

Other funds holding NEUE

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return

Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return

Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Dixon Hubard Feinour & Brown's NEUE Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown opened a new position in NeueHealth (NEUE) in Q2 2022: 188 shares worth $27K. The stake represents ﹤0.01% of the portfolio and ranks #278 among its holdings.

128 funds tracked by Wall St. Rank hold NEUE as of Q2 2022.

Dixon Hubard Feinour & Brown held 188 shares of NeueHealth worth $27K as of Q2 2022.
NeueHealth was a new Dixon Hubard Feinour & Brown position in Q2 2022.
NeueHealth made up ﹤0.01% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #278 holding.
128 funds tracked by Wall St. Rank held NeueHealth as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.